РусскийEnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Movchan O. D.

    PHARMACODYNAMIC MECHANISMS FOR DEVELOPMENT OF TOLERANCE TO ACTION OF ANTICONVULSANT DRUGS


    About the author: Movchan O. D.
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation The development of the tolerance to the anticonvulsant drugs is one of essential problems of epilepsy treatment. In this regard, the question arises concerning the development of the approaches to eliminate the tolerance to anticonvulsants. However, it is possible to solve this problem only on a theoretical basis of determination of the principles and mechanisms of the development of tolerance to the different anticonvulsant drugs. The aim of the research was to determine the functional state of the neurotransmitter systems using selective agonists and antagonists of different types of receptors. Materials and methods. Experiments were conducted on the nonlinear white mice, males and females, weighing 18-20 g. The study anticonvulsants included phenobarbital, 20 mg/kg, carbamazepine, 125 mg/kg, depakine, 155 mg/kg. Experimental seizures were modeled using intraperitoneal administration of the chemoconvulsants. GABA receptor antagonists include picrotoxin (6 mg/kg) and corazol (100 mg/kg), bikukulline (20 mg/kg), and the GABA synthesis inhibitor thiosemicarbazide (20 mg/kg). They were used to analyze the GABA-ergic system. The role of the glycinergic system and glutamatergic system were performed using glycine receptor antagonist strychnine (1.5 mg/kg) and glutamate receptor agonist kainic acid (30 mg/kg). Results Significant changes in functioning of the GABA-ergic neurotransmitter system of the brain are observed under the development of tolerance to the anticonvulsant action of phenobarbital. No another brake glycinergic and the excitatory glutamatergic systems were involved in the mechanisms of tolerance to anticonvulsant action of phenobarbital. It was shown that the GABA-ergic mechanism take part in the development of tolerance to carbamazepine. Probably glycinergic component in the mechanism of action of carbamazepine do not play a essential role in the development of tolerance to that drug. Тhе GABA-ergic system is also involved in the formation of tolerance to the anticonvulsant action of depakine. Conclusions The part of the GABA-, glycine- and glutamatergic systems of the brain in the mechanisms of action of anticonvulsant drugs was investigated. It has been shown that the effect of anticonvulsant drugs phenobarbital, carbamazepine, depakine offset in tolerant animals in the model corazol, picrotoxin, bicuculline and thiosemicarbazide convulsions. No differences in functioning of the glycine- and glutamatergic systems have been found between intolerant animals and animals tolerant to the action of phenobarbital and carbamazepine.
    Tags anticonvulsant drugs, tolerance, GABA-, glycine- and glutamatergic systems
    Bibliography
    • Gatsura V. V. Metodyi pervichnogo farmakologicheskogo issledovaniya biologicheski aktivnyih veschestv / V. V. Gatsura // – M.: Meditsina, - 1974. – 142 s.
    • Drogovoz S. M. Farmakologiya na ladonyah / S. M. Drogovoz // – Harkov, - 2007. – 110 s.
    • Kozhemyakin Yu. M. Naukovo-praktichni rekomendatsiyi z utrimannya laboratornih tvarin ta robot i z nimi / Yu. M. Kozhemyakin, O. S. Hromov, M. A. Filonenko [ta in.]. // – Kyiv, - 2002. – 155 s.
    • Lapach S. N. Statisticheskie metodyi v mediko-biologicheskih issledovaniyah s ispolzovaniem Excel / S. N. Lapach, A. V. Chubenko, P. N. Babich // – K.: Morion, - 2001. – 314 s.
    • Opryishko V. I. Issledovanie vzaimodeystviya karbamazepina i tiotriazolina na modeli farmakorezistentnoy epilepsii / V. I. Opryishko // Zaporozhskiy meditsinskiy zhurnal. – 2008. – No. 4 (49). – S. 31-35.
    • European convention for the protection of vertebrate animals used for experimental and other scientific purposes // Council of Europe, - Strasbourg, 1986 – 53 p.
    • French J. A. Refractory epilepsy: clinical overview / J. A. French // Epilepsia. - 2007. – Vol. 48 (Suppl 1). – P. 3-7.
    • Landmark C.J. Targets for antiepileptic drugs in the synapse / C. J. Landmark // Med. Sci. Monit. – 2007. – Vol. 13, № 1. – P. 1-7.
    • Macdonald R. L. Principles of antiepileptic drug action / R. L. Macdonald, B. S. Meldrum // – N.Y.: Raven Press, Ltd, - 1995. – P. 61-77.
    • Meldrum B. S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology / B. S. Meldrum // J Nutr. – 2000. – Vol. 130(4S Suppl). – P. 1007-1015.
    • STATISTICA 6. Статистический анализ данных / А.А. Халафян // – М.: Бином-Пресс, - 2007. – 512 с.
    • White H. S. Mechanism of action of antiepileptic drugs / H. S. White, M. D. Smith, K. S. Wilcox // Int Rev Neurobiol. – 2007. – Vol. 81. – P. 85-110.
    Publication of the article «World of Medicine and Biology» №3(52) 2 part 2015 year, 121-124 pages, index UDK 615.213: 615.015.4